Nita Radhakrishnan/OncoDaily
Aug 3, 2026, 08:57
Nita Radhakrishnan: Moving Beyond Half-Life in Hemophilia Prophylaxis at NHU 2026
Nita Radhakrishnan, Additional Professor and HOD of Pediatric Hematology-Oncology at Post Graduate Institute of Child Health, shared on LinkedIn:
“Discussed at NHU 2026 Indian Association for Haemophilia and Allied Disorders
Looking beyond t½ of EHL products: Individualized prophylaxis based on clearance, time above target, clinical phenotype, and shared decision-making.”
Stay updated with Hemostasis Today.
-
Aug 3, 2026, 09:25Sandeep De: Unraveling the Long-Term Impact of COVID-19 in Hemophilia
-
Aug 3, 2026, 08:47Neetu Gaur: Why Platelets Matter More Than You Think
-
Aug 3, 2026, 07:17Filippo Cademartiri: Treating Atherosclerosis Rather Than Its Probability
-
Aug 3, 2026, 03:18Ajay Samkaria: Every Unexpected Antibody Tells a Story
-
Aug 3, 2026, 03:06Abdul Mannan: The Most Important Tube in the FXIII Assay
-
Aug 3, 2026, 02:29Herman Sandeep Prakasam: Who Is Missing Anticoagulation?
-
Aug 2, 2026, 23:07Akshat Jain: Redefining Hemophilia Readiness in Mexico
-
Aug 2, 2026, 16:24Satish Medakkar: The Importance of Early Recognition in Atypical Hemolytic Uremic Syndrome
-
Aug 2, 2026, 16:07Mirjavad Mammadov: Understanding the Thrombotic Paradox of Heparin Therapy